The Hypothesis: Metabolic Parsimony as an Oncogenic Shunt

I’m proposing that the age-related upregulation of the Apical Sodium-dependent Bile Acid Transporter (ASBT) in the ileum acts as a metabolic-to-oncogenic shunt. This mechanism likely compensates for the systemic decline in canonical Wnt signaling by using high intracellular bile acid (BA) concentrations to kickstart YAP-driven regeneration. While this keeps the intestinal barrier intact in the short term—a basic requirement for staying alive—it creates a state of "phantom injury" signaling that eventually triggers neoplastic transformation.

The Mechanistic Conflict

In a young intestine, homeostatic turnover is mostly handled by the Wnt signaling pathway, which keeps intestinal stem cells (ISCs) multipotent and self-renewing. However, aging is defined by a sharp drop in canonical Wnt [PMC9745321]. To prevent the epithelium from simply collapsing, the intestine has to find another mitogenic driver.

At the same time, we see that ileal ASBT expression actually increases as we age [PMC11148718], even though de novo hepatic bile acid synthesis is slowing down. Evolution seems to have prioritized the energetic parsimony of recycling BAs over the high metabolic cost of making them. I suspect this "bile acid pressure cooker" within the ileal enterocyte isn't just a passive byproduct of aging; it’s a functional replacement for Wnt.

The "Phantom Injury" Mechanism

High concentrations of intracellular BAs, particularly the hydrophobic species, are known to activate the Hippo pathway effector YAP through FXR-mediated crosstalk and TGR5 signaling. Under normal circumstances, YAP activation is a fallback for acute tissue injury [PubMed 21041407]. In the aged ileum, I’d argue that the increased ASBT flux chronically triggers this "emergency" regenerative program.

This leads to a dangerous trade-off:

1. Short-term Survival: The BA-YAP axis keeps ISCs proliferating when Wnt fails, staving off villus atrophy and malabsorption.
2. Long-term Malignancy: Because YAP is naturally oncogenic when it’s decoupled from Hippo-mediated "stop" signals, this chronic activation fuels the growth of early-onset polyps and adenomas.

It looks like an evolutionary gamble—a bet that the organism would succumb to predation or environmental stress before this BA-driven regenerative shunt could accumulate the secondary mutations needed for a full-blown carcinoma.

Testability and Falsification

We can test this by looking at how aged ISCs handle different metabolic pressures:

• Prediction 1: Pharmacological inhibition of ASBT in aged mice (using a drug like odevixibat) should cause a rapid decline in ileal epithelial integrity because the "YAP shunt" is lost while Wnt levels remain low.
• Prediction 2: Knocking out YAP in aged ileal organoids should stop the compensatory growth we usually see in high-bile environments, whereas young organoids (which are Wnt-dominant) won't be affected.
• Falsification: If aged ISCs can maintain turnover without Wnt or ASBT-mediated BA flux, or if ASBT-driven YAP activation doesn't happen before polyps form in aging models, the hypothesis is wrong.

Final Thoughts

We aren't just "metabolically stranding ourselves" as we age; we're switching over to a secondary, much more dangerous regenerative engine. The age-related climb in ASBT is the signature of an organism desperately recycling its metabolic waste to power a signaling pathway it can no longer regulate.